stents that can be navigated through the intracranial circulation. However, the main difficulty exists on the correct positioning of the stent at the lesion especially in focal stenosis on the middle cerebral artery. We report the usefulness of external marking in stenting with a symptomatic M1 segment of middle cerebral artery stenosis.
Technical Notes
A 43-year-old man with a history of hypertension and diabetes presented with a history of a left-side hemiparesis, dysarthria, and mild ataxia. Magnetic resonance imaging scans and angiogram (MRI and MRA) demonstrated multiple small infarctions along the upper trunk territory of the right middle cerebral artery and a focal severe narrowing at the M1 distal portion of the right middle cerebral artery. Cerebral angiogram confirmed about 70% of a focal stenosis on the distal M1 portion of the right middle cerebral artery ( figure  1A ). There was significant flow reduction at the baseline 99 mTc-ECD(Ethyl cysteinate dimer) SPECT(single photon emission computed tomography) and an acetazolamide provocative 99 mTc-ECD SPECT on the territory of the right middle cerebral artery. Despite therapeutic heparinization and antiplatelet therapy, the patient experienced two more episodes while
Summary
In intracranial stenting procedures, especially for a focal stenosis on the M1 portion of the middle cerebral artery, the anatomical configuration of the middle cerebral artery is changed with the advance of a rigid stent catheter. Therefore, the location of the stenotic portion where the stent is supposed to be deployed, according to pre-measurements on the roadmapping image, could be changed to some degrees. To prevent this error, we put a 30 gauge needle with cap at the orbital rim on the same preliminary vertical line of the distal end of the stenotic portion where the distal end of the stent is supposed to be deployed and the stent deployment is performed under guidance of the external marking on the fluoroscopic image not under roadmapping image. We report our experience of successful elective stenting of middle cerebral artery stenosis using the aid of external marking.
Introduction
With the recent advances in technology and flexible stents that can be navigated through the intracranial circulation, stenting of the middle cerebral artery stenosis has been accepted as a technically possible procedure 1 . Difficulties in tracking have been overcome with the recent advances in technology and flexible The Usefulness of External Marking in Stenting for M1 Segment of Middle Cerebral Artery Stenosis awaiting a decision concerning his therapy. After meticulous discussion with neurologists and radiologists, we decided to treat the lesion with stent insertion.
After obtaining percutaneous access via the right femoral, 6-French sheath was inserted. A 6-French guiding catheter (Guider, Target Therapeutics, Freemont, U.S.A.) was advanced into the cervical portion of the left internal carotid artery. Cerebral angiography performed and it demonstrated findings similar to the previous angiogram.
The patient underwent full heparinization, using intravenously administered loading dose followed by a continuous intravenous infusion. The guiding catheter was connected to a continuous heparinized saline flush. Pre-procedural angiographic images were then obtained in antero-posterior planes and a 30 gauge needle with cap was positioned at the orbital rim on the same preliminary vertical line of the distal end of the stenotic portion where the distal end of the stent is supposed to be deployed ( figure  1B, C) .
Under the roadmapping image, the lesion was crossed with a 182 cm microwire (Choice PT, Scimed Maple Grove, U.S.A.). Then, a 2.5 mm diameter, 12 mm length S660 coronary stent (S660 2512XD, AVE, Metronic Inc, Minneapolis, U.S.A.) was advanced over the exchange wire and positioned across the stenosis using the roadmapping technique. The stent catheter can be advanced under the roadmapping image; however, the stent deployment absolutely depends on the location of the needle on the fluoroscopic image, not by following the stenotic segment which is documented on the roadmapping image since it has been already been displaced to some degree by the advancement of the stiff stent catheter.
After confirming correct stent positioning under the external marking, it was deployed by inflating the balloon to 6 atm for 15 seconds. The right ICA angiogram immediately after stent placement showed sufficient and smooth dlatation of the lesion, with preservation of the lenticulostriate arteries. Neither dissection nor vessel irregularity was noted ( figure 1D ). No neurologic events occurred during the procedure.
Heparin was continuously infused for up to 24 hours with maintenance of PTT 2-2.5 times higher than the normal range. The patient continued to receive aspirin and clopidogrel. Two days later, a diffusion magnetic resonance imaging revealed no evidence of recent infarction.
A baseline 99 mTc-ECD SPECT and an acetazolamide provocative 99 mTc-ECD SPECT demonstrated improved blood flow at the right middle cerebral artery territory compared with pre-procedural images. The patient was discharged without complications.
Discussion
Intracranial stenting has been used as one of the treatment modalities for intracranial atherosclerotic disease when medical and surgical alternatives have failed or cannot be applied 2-6 . However, stenting of the middle cerebral artery, has been limited due to tracking difficulties and the paucity of experiences with intracranial deployment of small stents 1 . There are two main technical difficulties in stenting the M1 portion of the middle cerebral artery. First, it is difficult to track stents across the carotid siphon.
This has been overcome with the recent advances in technology and flexible stents that can be navigated through the intracranial circulation. Careful patient selection is also very important; good candidates for stent insertion are patients with good anatomically friendly intracranial carotid artery, who are relatively young. The other difficulty is the correct positioning of the stent at the lesion. Because of the relative stiffness of the stent, the anatomical configuration of the middle cerebral artery is supposed to be changed with the advance of rigid stent catheter. For example, with the advancement of the stent catheter, the somewhat curved-inferiorly middle cerebral artery tends to be straightforward which causes obliteration of the roadmapping image that leads to wrong location of the stents. The stent deployment should depend on the location of the needle on the fluoroscopic image not the roadmapping image. This is one of the most important pitfalls for intracranial stenting procedures.
